Nan Fung Ltd 13F annual report

Nan Fung Ltd is an investment fund managing more than $93.7 billion ran by Tang Nelson. There are currently 44 companies in Nelson’s portfolio. The largest investments include Illumina Inc and Harmony Biosciences Hldgs In, together worth $23.6 billion.

Limited to 30 biggest holdings

$93.7 billion Assets Under Management (AUM)

As of 6th August 2024, Nan Fung Ltd’s top holding is 119,196 shares of Illumina Inc currently worth over $12.4 billion and making up 13.3% of the portfolio value. Relative to the number of outstanding shares of Illumina Inc, Nan Fung Ltd owns more than approximately 0.1% of the company. In addition, the fund holds 368,665 shares of Harmony Biosciences Hldgs In worth $11.1 billion. The third-largest holding is Merus N.V worth $7.1 billion and the next is Geron worth $5.82 billion, with 1,373,550 shares owned.

Currently, Nan Fung Ltd's portfolio is worth at least $93.7 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Nan Fung Ltd

The Nan Fung Ltd office and employees reside in Kai Tak, Hong Kong. According to the last 13-F report filed with the SEC, Tang Nelson serves as the Director at Nan Fung Ltd.

Recent trades

In the most recent 13F filing, Nan Fung Ltd revealed that it had opened a new position in Geron and bought 1,373,550 shares worth $5.82 billion. This means they effectively own approximately 0.1% of the company. Geron makes up 9.6% of the fund's Health Care sector allocation and has decreased its share price by approximately 0.1% in the past year.

The investment fund also strengthened its position in Merus N.V by buying 26,288 additional shares. This makes their stake in Merus N.V total 120,038 shares worth $7.1 billion. Merus N.V dropped approximately 0.1% in the past year.

On the other hand, there are companies that Nan Fung Ltd is getting rid of from its portfolio. Nan Fung Ltd closed its position in Karuna Therapeutics Inc on 13th August 2024. It sold the previously owned 225,688 shares for $44.3 billion. Tang Nelson also disclosed a decreased stake in Xenon Pharmaceuticals Inc by approximately 0.1%. This leaves the value of the investment at $4.16 billion and 106,680 shares.

One of the smallest hedge funds

The two most similar investment funds to Nan Fung Ltd are Vestia Personal Wealth Advisors and Incentive As. They manage $93.7 billion and $93.8 billion respectively.


Tang Nelson investment strategy

Nan Fung Ltd’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 65.0% of the total portfolio value. The fund focuses on investments in the United States as 47.7% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 9% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $4.69 billion.

The complete list of Nan Fung Ltd trades based on 13F SEC filings

These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Karuna Therapeutics Inc
Closed
225,688
$44,347,692,000
Illumina Inc
No change
119,196
$12,441,678,000 13.27%
Harmony Biosciences Hldgs In
No change
368,665
$11,122,623,000 11.87%
Merus N.V
28.04%
120,038
$7,102,648,000 7.58%
Seagen Inc
Closed
47,096
$6,052,307,000
Geron Corp.
Opened
1,373,550
$5,823,852,000 6.21%
Oculis Holding Ag
Opened
436,378
$5,214,717,000 5.56%
Incyte Corp.
115.24%
74,022
$4,487,214,000 4.79%
Exscientia Plc
0.80%
859,892
$4,385,449,000 4.68%
Somalogic Inc
Closed
1,696,558
$4,258,361,000
Xenon Pharmaceuticals Inc
6.73%
106,680
$4,159,453,000 4.44%
Longboard Pharmaceuticals In
Opened
144,570
$3,907,727,000 4.17%
Mirum Pharmaceuticals Inc
Opened
106,100
$3,627,559,000 3.87%
Standard BioTools Inc
Opened
1,883,179
$3,333,227,000 3.56%
BeiGene Ltd
91.50%
23,022
$3,284,549,000 3.50%
Chinook Therapeutics, Inc.
Closed
113,950
$2,985,490,000
KalVista Pharmaceuticals Inc
178.55%
219,277
$2,583,083,000 2.76%
IVERIC bio Inc
Closed
111,984
$2,397,577,000
Rhythm Pharmaceuticals Inc.
51.05%
49,120
$2,016,867,000 2.15%
Tourmaline Bio Inc
Opened
146,800
$1,887,848,000 2.01%
Rani Therapeutics Hldgs Inc
No change
493,584
$1,875,619,000 2.00%
Ascendis Pharma A/S
226.30%
13,600
$1,854,768,000 1.98%
Replimune Group Inc
8.24%
204,939
$1,844,451,000 1.97%
Eargo, Inc.
Closed
2,958,099
$1,700,907,000
Acadia Pharmaceuticals Inc
243.46%
102,984
$1,673,490,000 1.79%
Madrigal Pharmaceuticals Inc
380.71%
5,682
$1,591,869,000 1.70%
Exelixis Inc
No change
64,200
$1,442,574,000 1.54%
Zai Lab Ltd
Opened
55,000
$953,150,000 1.02%
Galera Therapeutics Inc
Closed
613,223
$913,702,000
Biomarin Pharmaceutical Inc.
76.86%
10,815
$890,399,000 0.95%
Bolt Biotherapeutics Inc
No change
1,166,952
$875,214,000 0.93%
Entrada Therapeutics Inc
33.30%
49,082
$699,419,000 0.75%
Dbv Technologies S A
Closed
370,950
$567,554,000
Travere Therapeutics Inc
Closed
25,606
$538,494,000
Athira Pharma, Inc.
Opened
180,000
$477,000,000 0.51%
Affimed N.V.
Closed
372,472
$461,865,000
Argenx Se
Closed
1,110
$420,501,000
Pacific Biosciences Calif In
100.86%
274,488
$376,049,000 0.40%
Cabaletta Bio Inc
Opened
47,150
$352,682,000 0.38%
Bicycle Therapeutics plc
Opened
17,300
$350,152,000 0.37%
Roivant Sciences Ltd
Opened
32,470
$343,208,000 0.37%
Kymera Therapeutics, Inc.
Opened
10,875
$324,619,000 0.35%
GitLab Inc.
Closed
6,910
$313,990,000
Grail Inc
Opened
19,866
$305,340,000 0.33%
Revolution Medicines Inc
Opened
7,300
$283,313,000 0.30%
SpringWorks Therapeutics, Inc.
Opened
7,450
$280,642,000 0.30%
ALX Oncology Holdings Inc.
No change
41,950
$252,959,000 0.27%
Immunocore Hldgs Plc
Opened
6,750
$228,758,000 0.24%
Affimed N.V.
Opened
37,247
$202,996,000 0.22%
Immatics N.v
Opened
15,700
$182,434,000 0.19%
Biomea Fusion Inc
33.33%
40,000
$180,000,000 0.19%
Satsuma Pharmaceuticals, Inc.
Closed
177,900
$160,110,000
AbCellera Biologics Inc.
307.08%
50,971
$150,874,000 0.16%
Dbv Technologies S A
Opened
185,475
$148,565,000 0.16%
Nurix Therapeutics, Inc.
Closed
11,500
$126,270,000
Aerovate Therapeutics Inc
5.29%
47,936
$79,574,000 0.08%
Kodiak Sciences Inc
62.68%
31,922
$75,017,000 0.08%
FibroGen Inc
82.10%
62,106
$55,417,000 0.06%
Synlogic Inc
Closed
68,634
$52,162,000
Cerus Corp.
Closed
14,172
$51,728,000
Invitae Corp
Closed
11,337
$21,087,000
No transactions found
Showing first 500 out of 61 holdings